Independent register of U.S. FDA drug recalls · updated Oct 10, 2026
RxRecalls Get alerts

Particulate & foreign matter

Visible foreign particles - glass, metal, fibers or other material - found in the product. Particles can enter from equipment wear, containers or the process, and are dangerous in injectables.

867 FDA drug recalls with this cause, newest first.

These recalls involve visible foreign material - glass, metal, fibers, rubber or other debris - most often found in injectable or liquid products, where nothing besides the intended ingredients should be present. It also includes foreign tablets or capsules found in a bottle of a different product. In an injectable a stray particle can go straight into the bloodstream, which is why a noticeable share of these recalls are Class I.

Class II · Moderate risk

Levetiracetam Tablets

Presence of foreign tablet/capsule: A 1000 mg Levetiracetam Tablet was found in 500 gram bottle of Levetiracetam Tablets.

Terminated Particulate / foreign matter Eywa Pharma INC NDC 71930-063-52 D-0109-2021
Class II · Moderate risk

Lisinopril Tablets USP

Presence of Foreign Tablets/Capsules: Lisinopril Tablets USP, 20mg found in a 1000 count bottle of Lisinopril Tablets USP, 10mg

Terminated Particulate / foreign matter Lupin Pharmaceuticals Inc. NDC 68001-334-08 D-1413-2020
Class II · Moderate risk

Clozapine Tablets USP tablet

Presence of foreign tablet: Consumer complaint of Clozapine Tablets 50mg being present in 500 count bottles of Clozapine Tablets USP 100mg.

Terminated Particulate / foreign matter Aurobindo Pharma USA Inc. NDC 65862-846-05 D-1370-2020
Class III · Low risk

Lamotrigine Tablets

Presence of Foreign Substance visually consistent with the silica granules present in the desiccant packs utilized during storage of the product.

Terminated Particulate / foreign matter Jubilant Cadista Pharmaceuticals, Inc. NDC 59746-247-97 D-1281-2020
Class II · Moderate risk

Estradiol

cGMP deviations: Presence of foreign material (Teflon)introduced at the production level.

Terminated Particulate / foreign matter B & B Pharmaceuticals, Inc. NDC 63275-9900-8 D-1244-2020
Class II · Moderate risk

Lisinopril Tablets USP

Presence of Foreign Tablet/ Capsule: Product complaint received indicating mix-up of one lisinopril 5mg tablet inside of a 30 mg, 100-count bottle of Lisinopril Tablets.

Terminated Particulate / foreign matter Lupin Pharmaceuticals Inc. NDC 68180-982-01 D-1079-2020
Class III · Low risk

Tacrolimus Capsules

Presence of foreign tablet/capsule - Potential presence of commingled one Tacrolimus 1 mg capsule in 5 mg bottles.

Terminated Particulate / foreign matter Mylan Pharmaceuticals Inc. NDC 0378-2047-01 D-1057-2020
Class II · Moderate risk

Atorvastatin Calcium Tablets

Presence of foreign substance: Foreign matter has been identified as latex glove in one lot of Atorvastatin Calcium Tablets USP 40 mg.

Terminated Particulate / foreign matter Sun Pharmaceutical Industries, Inc. NDC 63304-829-05 D-1047-2020